Roberto Diaz, MD specializes in the treatment of gynecologic malignancies and high-dose rate brachytherapy in the treatment of malignancies.
Dr. Diaz has authored and co-authored numerous scientific articles for publication in international and national peer-reviewed journals like Nature Medicine and Cancer Research, as well as for presentation at international and national research meetings.
Originally from the Dominican Republic, Dr. Diaz is fluent in both Spanish and English. Prior to joining our faculty, he has lived in Santo Domingo, Manhattan, and Nashville. Dr. Diaz looks forward to establishing new roots both at Emory and in the Atlanta community.
Dr. Diaz’s has research interests both in the laboratory and in clinic. His laboratory research includes discovery of biomarkers for metastatic breast cancer, targeted drug delivery, and assessment of brain tumor susceptibility to molecular targeted therapy. During his time as a Holman Pathway resident at Vanderbilt, he was awarded grants from the Department of Defense, the American Society for Radiation Oncology (ASTRO), and the Radiological Society of North America (RSNA).
For his work, he has won numerous national awards including the Resident Basic Science Research Award from AS-TRO and the RSNA Roentgen Resident/Fellow Research Award (2008). His clinical research includes a bevy of work on radiation therapy in head and neck cancer.
At Emory, Dr. Diaz runs his own translational research lab with a team of talented young scientists. One of his greatest joys is mentoring students, both medical and doctoral, that work in his lab. His past students have gone on to successful careers in medicine and research with numerous publications and honors in the fields of radiation oncology and cancer biology.
Roberto Diaz, MD, PhD, graduated summa cum laude from Manhattanville College with a degree in chemistry. He earned his MS, PhD, and MD degrees from New York University School of Medicine where he completed the medical scientist training program with an emphasis on molecular oncology. After graduating, he spent his first year of residency in Internal Medicine at Yale University’s Griffin Hospital. At Griffin, he was voted best first-year resident by the nursing staff. He then completed his training in Radiation Oncology at Vanderbilt University where he served as chief resident in his final year.